Copyright
©The Author(s) 2016.
World J Gastroenterol. Dec 14, 2016; 22(46): 10254-10259
Published online Dec 14, 2016. doi: 10.3748/wjg.v22.i46.10254
Published online Dec 14, 2016. doi: 10.3748/wjg.v22.i46.10254
Figure 5 One month post-olaparib treatment (August 23, 2015).
Computed tomography of the abdomen revealed shrinkage in both the intra- and extra-hepatic lesions and extra-hepatic lesions even appeared to be invisible.
- Citation: Xie Y, Jiang Y, Yang XB, Wang AQ, Zheng YC, Wan XS, Sang XT, Wang K, Zhang DD, Xu JJ, Li FG, Zhao HT. Response of BRCA1-mutated gallbladder cancer to olaparib: A case report. World J Gastroenterol 2016; 22(46): 10254-10259
- URL: https://www.wjgnet.com/1007-9327/full/v22/i46/10254.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i46.10254